Part of
Contextualizing Pragma-Dialectics
Edited by Frans H. van Eemeren and Peng Wu
[Argumentation in Context 12] 2017
► pp. 7792
Bell, Robert A., Richard L. Kravitz and Michael S. Wilkes
(2000) “Direct-to-consumer Prescription Drug Advertising, 1989–1998: A content Analysis of Conditions, Targets, Inducements and Appeals.” The Journal of Family Practice, 49(4): 329–335.Google Scholar
Calfee, John E.
(2002) “Public Policy Issues in Direct-to-consumer Advertising of Prescription Drugs.” Journal of Public Policy and Marketing, 21(2): 174–193. DOI logoGoogle Scholar
Cohen, Eric P.
(1990) “Are Pharmaceutical Ads Good Medicine?” Business and Society Review, 2: 8–10Google Scholar
Goodnight, G. Thomas
(2008) “Strategic Maneuvering in Direct to Consumer Drug Advertising: A Study in Argumentation Theory and New Institutional Theory.” Argumentation, 22(3): 359–371. DOI logoGoogle Scholar
Harker, Michael and Debra Harker
(2007) “Direct-to-consumer Advertising of Prescription Medicines: A Systematic Review of the Evidence from the Perspective of the Consumer.” Journal of medical Marketing, 7:45–54. DOI logoGoogle Scholar
Huh, Jisu, Denise E. DeLorme, Leonard N. Reid and Soontae An
(2010) “Direct-to-Consumer Prescription Drug Advertising: History, Regulation, and Issues.” Minnesota Medicine March 2010: 50–52.Google Scholar
Levinson, Stephen C.
(1992) “Activity Types and Language.” In Talk at Work: Interaction in Institutional Settings, edited by Paul Drew and John Heritage, 66–100. Cambridge: Cambridge University Press.Google Scholar
Mohammed, Dima and Peter Schulz
(2011) “Argumentative Insights for the Analysis of Direct-to-consumer Advertising.” In Proceedings of the seventh ISSA conference on argumentation, edited by F. H. van Eemeren, B. Garssen, D. Godden and G. Mitchell, 1322–1333. Amsterdam: Sic Sat.Google Scholar
Orizio, Grazia, Peter Schulz, Serena Domenighini, Maura Bressanelli, Sara Rubinelli, Luigi Caimi and Umberto Gelatti
(2009) “Online Consultations in Cyberpharamcies: Completeness and Patient Safety.” Telemedicine and e-Health, 15(10): 1022–1025. DOI logoGoogle Scholar
Rubinelli, Sara, Kent Nakamoto and Peter Schulz
(2008) “The Rabbit in the Hat: Dubious Argumentation and the Persuasive Effects of Prescription Drug Advertising.” Communication & Medicine, 5(1):49–58. DOI logoGoogle Scholar
van Eemeren, Frans H. and Bart Garssen
(2009) “In Varietate Concordia – United in Diversity: European Parliamentary Debate as an Argumentative Activity Type.” Controversia, 7(1):19–37.Google Scholar
van Eemeren, Frans H. and Rob Grootendorst
(1984) Speech Acts in Argumentative Discussions. Berlin: de Gruyter. DOI logoGoogle Scholar
(2004) A Systematic Theory of Argumentation: The Pragma-dialectical Approach. Cambridge: Cambridge University Press.Google Scholar
van Eemeren, Frans H. and Peter Houtlosser
(2002) “Strategic Maneuvering in Argumentative Discourse: Maintaining a Delicate Balance.” In Dialectic and Rhetoric: The Warp and Woof of Argumentation Analysis, edited by F. H. van Eemeren and P. Houtlosser, 131–159. Dordrecht: Kluwer. DOI logoGoogle Scholar
van Haaften, Ton
(2011) “Dutch Parliamentary Debate as Communicative Activity Type.” In Proceedings of the seventh ISSA conference on argumentation, edited by F. H. van Eemeren, B. Garssen, D. Godden and G. Mitchell, 687–695. Amsterdam: Sic Sat.Google Scholar
van Poppel, Lotte and Sara Rubinelli
(2011) “‘Try the Smarter Way’: On the Claimed Efficacy of Advertised Medicines.” In Keeping in Touch with Pragma-Dialectics, edited by Eveline Feteris, Bart Garssen and Francisca Snoeck Henkemans, 153–163. Amsterdam: John Benjamins. DOI logoGoogle Scholar
Cited by

Cited by 1 other publications

Bogaards, Maarten
2021. “Completely impartial opinion, okay?”. Journal of Argumentation in Context 10:3  pp. 368 ff. DOI logo

This list is based on CrossRef data as of 22 may 2024. Please note that it may not be complete. Sources presented here have been supplied by the respective publishers. Any errors therein should be reported to them.